Publications

  1. Conover CA, Bale LK, Stan MN. PAPP-A as a Potential Target in Thyroid Eye Disease. J Clin Endocrinol Metab. 2024 Nov 18; 109 (12):3119-3125
    View PubMed
  2. Rachmasari KN, Schmitz JJ, Castro MR, Kurup AN, Lee RA, Stan MN. Exploring Radiofrequency Ablation for T1 Papillary Thyroid Cancer in the United States: Mayo Clinic Experience. Mayo Clin Proc. 2024 Nov; 99 (11):1702-1709 Epub 2024 Aug 02
    View PubMed
  3. Dhanasekaran M, Schmitz J, Castro MR, Rajwani A, Lee RA, Hamadi D, Morris JC 3rd, Callstrom MR, Stan MN. Outcomes of Radiofrequency Ablation for Autonomously Functioning Thyroid Adenomas-Mayo Clinic Experience. J Endocr Soc. 2024 Oct 29; 8 (12):bvae175 Epub 2024 Oct 17
    View PubMed
  4. Rachmasari KN, Hamadi D, Thapa P, Bradley EA, Stan MN. The Epidemiology of Thyroid Eye Disease in Olmsted County, Minnesota, 2005-2020. Thyroid. 2024 Oct 7 Epub 2024 Oct 07
    View PubMed
  5. Rachmasari KN, Toro-Tobon D, Wagner LH, Tooley AA, Bradley EA, Stan MN. Impact of Teprotumumab on Clinical Practice in Thyroid Eye Disease. Endocr Pract. 2024 Oct; 30 (10):937-942 Epub 2024 June 25
    View PubMed
  6. Singh Ospina N, Patel Chavez C, Godinez Leiva E, Bagautdinova D, Hidalgo J, Hartasanchez S, Algarin Perneth S, Barb D, Danan D, Dziegielewski P, Hughley B, Srihari A, Subbarayan S, Castro MR, Dean D, Morris J, Ryder M, Stan MN, Hargraves I, Bylund CL, Treise D, Montori VM, Brito JP. Clinician feedback using a shared decision-making tool for the evaluation of patients with thyroid nodules-an observational study. Endocrine. 2024 Feb; 83 (2):449-458 Epub 2023 Sept 11
    View PubMed
  7. Douglas RS, Couch S, Wester ST, Fowler BT, Liu CY, Subramanian PS, Tang R, Nguyen QT, Maamari RN, Ugradar S, Hsu K, Karon M, Stan MN. Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity. J Clin Endocrinol Metab. 2023 Dec 21; 109 (1):25-35
    View PubMed
  8. Kahaly GJ, Dolman PJ, Wolf J, Giers BC, Elflein HM, Jain AP, Srinivasan A, Hadjiiski L, Jordan D, Bradley EA, Stan MN, Eckstein A, Pitz S, Vorlander C, Wester ST, Nguyen J, Tucker N, Sales-Sanz M, Feldon SE, Nelson CC, Hardy I, Abia-Serrano M, Tedeschi P, Janes JM, Xu J, Vue P, Macias WL, Douglas RS. Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease. J Clin Endocrinol Metab. 2023 Nov 17; 108 (12):3122-3134
    View PubMed
  9. Toro-Tobon D, Rachmasari KN, Bradley EA, Wagner LH, Tooley AA, Stokken JK, Stan MN. Medical Therapy in Patients with Moderate to Severe, Steroid-Resistant, Thyroid Eye Disease. Thyroid. 2023 Oct; 33 (10):1237-1244 Epub 2023 Aug 23
    View PubMed
  10. Salas-Lucia F, Stan MN, James H, Rajwani A, Liao XH, Dumitrescu AM, Refetoff S. Effect of the Fetal THRB Genotype on the Placenta. J Clin Endocrinol Metab. 2023 Sep 18; 108 (10):e944-e948
    View PubMed
  11. Stan MN, Krieger CC. The Adverse Effects Profile of Teprotumumab. J Clin Endocrinol Metab. 2023 Aug 18; 108 (9):e654-e662
    View PubMed
  12. Kumar R, LeMahieu AM, Stan MN, Seshadri A, Ozerdem A, Pazdernik VK, Haynes TL, Daugherty DH 3rd, Sundaresh V, Veldic M, Croarkin PE, Frye MA, Singh B. The Association Between Thyroid Stimulating Hormone and Depression: A Historical Cohort Study. Mayo Clin Proc. 2023 Jul; 98 (7):1009-1020
    View PubMed
  13. Naser JA, Pislaru SV, Stan MN, Lin G. Incidence, Risk Factors, and Outcomes of Incident Atrial Fibrillation in Patients With Graves Disease. Mayo Clin Proc. 2023 Jun; 98 (6):883-891 Epub 2023 Mar 13
    View PubMed
  14. Patel Chavez CP, Godinez Leiva E, Bagautdinova D, Hidalgo J, Hartasanchez S, Barb D, Danan D, Dziegielewski P, Edwards C, Hughley B, Srihari A, Subbarayan S, Castro MR, Dean D, Morris J, Ryder M, Stan MN, Hargraves I, Shepel K, Brito JP, Bylund CL, Treise D, Montori V, Singh Ospina N. Patient feedback receiving care using a shared decision making tool for thyroid nodule evaluation-an observational study. Endocrine. 2023 Apr; 80 (1):124-133 Epub 2022 Dec 19
    View PubMed
  15. Sousa C, Garovic VD, Stan M, Fervenza FC, Kattah A. Thyroid disease, Hypertension and Pregnancy: The need for balance illustrated in 2 cases. Am J Hypertens. 2023 Mar 30 [Epub ahead of print]
    View PubMed
  16. Nirmalan A, Blecher N, Hyder S, Couch SM, Godfrey KJ, Stan MN, Bradley EA, Wagner LH, Tooley AA. Alemtuzumab-Induced Thyroid Eye Disease: A Comprehensive Case Series and Review of the Literature. Ophthalmic Plast Reconstr Surg. 2023 Mar 9 Epub 2023 Mar 09
    View PubMed
  17. Joseph B, Nunez NA, Pazdernik V, Kumar R, Pahwa M, Ercis M, Ozerdem A, Cuellar-Barboza AB, Romo-Nava F, McElroy SL, Coombes BJ, Biernacka JM, Stan MN, Frye MA, Singh B. Long-Term Lithium Therapy and Thyroid Disorders in Bipolar Disorder: A Historical Cohort Study. Brain Sci. 2023 Jan 12; 13(1).
    View PubMed
  18. Burch HB, Perros P, Bednarczuk T, Cooper DS, Dolman PJ, Leung AM, Mombaerts I, Salvi M, Stan MN. Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association. Eur Thyroid J. 2022 Dec 1; 11 (6) Epub 2022 Dec 08
    View PubMed
  19. Burch HB, Perros P, Bednarczuk T, Cooper DS, Dolman PJ, Leung AM, Mombaerts I, Salvi M, Stan MN. Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association. Thyroid. 2022 Dec; 32 (12):1439-1470 Epub 2022 Dec 08
    View PubMed
  20. Navin PJ, Thompson SM, Kurup AN, Lee RA, Callstrom MR, Castro MR, Stan MN, Welch BT, Schmitz JJ. Radiofrequency Ablation of Benign and Malignant Thyroid Nodules. Radiographics. 2022 Oct; 42 (6):1812-1828
    View PubMed
  21. Sharma A, Stan MN, Rootman DB. Measuring Health-Related Quality of Life in Thyroid Eye Disease. J Clin Endocrinol Metab. 2022 Aug 8; 107 (Suppl_1):S27-S35
    View PubMed
  22. Naser JA, Pislaru S, Stan MN, Lin G. Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease. Heart. 2022 May 12; 108 (11):868-874
    View PubMed
  23. Stan MN, Papaleontiou M, Schmitz JJ, Castro MR. Nonsurgical Management of Thyroid Nodules: The Role of Ablative Therapies. J Clin Endocrinol Metab. 2022 Apr 19; 107 (5):1417-1430
    View PubMed
  24. Naser JA, Attia ZI, Pislaru SV, Stan MN, Pellikka PA, Noseworthy PA, Friedman PA, Lin G. Artificial Intelligence Application in Graves Disease: Atrial Fibrillation, Heart Failure and Menstrual Changes. Mayo Clin Proc. 2022 Apr; 97 (4):730-737 Epub 2022 Jan 22
    View PubMed
  25. Jasim S, Patel KN, Randolph G, Adams S, Cesareo R, Condon E, Henrichsen T, Itani M, Papaleontiou M, Rangel L, Schmitz J, Stan MN. American Association of Clinical Endocrinology Disease State Clinical Review: The Clinical Utility of Minimally Invasive Interventional Procedures in the Management of Benign and Malignant Thyroid Lesions. Endocr Pract. 2022 Apr; 28 (4):433-448
    View PubMed
  26. Stan MN, Algeciras-Schimnich A, Murthy V, Thapa P, Araki N. Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease. Thyroid. 2022 Feb; 32 (2):170-176 Epub 2021 Dec 31
    View PubMed
  27. Wagner LH, Bradley EA, Tooley AA, Ren Y, Rachmasari KN, Stan MN. Thyroid eye disease or Graves' orbitopathy: What name to use, and why it matters. Front Endocrinol (Lausanne). 2022; 13:1083886. Epub 2022 Nov 28.
    View PubMed
  28. Boonrod A, Akkus Z, Castro MR, Zeinodini A, Philbrick K, Stan M, Erickson D, Erickson B. Thyroid Nodule Size as a Predictor of Malignancy in Follicular and Hurthle Neoplasms. Asian Pac J Cancer Prev. 2021 Aug 1; 22 (8):2597-2602 Epub 2021 Aug 01
    View PubMed
  29. El Kawkgi OM, Ross DS, Stan MN. Comparison of long-term antithyroid drugs versus radioactive iodine or surgery for Graves' disease: A review of the literature. Clin Endocrinol (Oxf). 2021 Jul; 95 (1):3-12 Epub 2020 Dec 06
    View PubMed
  30. Iniguez-Ariza NM, Sharma A, Garrity JA, Stan MN. The "Quiet TED"-A Special Subgroup of Thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. 2021 Mar 24 [Epub ahead of print]
    View PubMed
  31. Cao C, Jasim S, Cherian A, Nassar A, Chindris AM, Rivas AM, Bonnett S, Caserta M, Stan MN, Bernet VJ. Patient Discomfort in Relation to Thyroid Nodule Fine-Needle Aspiration (FNA) Performed with or without Parenteral and/or Topical Anesthetic. Endocr Pract. 2020 Dec; 26 (12):1497-1504
    View PubMed
  32. Hay ID, Lee RA, Kaggal S, Morris JC, Stan MN, Castro MR, Fatourechi V, Thompson GB, Charboneau JW, Reading CC. Long-Term Results of Treating With Ethanol Ablation 15 Adult Patients With cT1aN0 Papillary Thyroid Microcarcinoma. J Endocr Soc. 2020 Nov 1; 4 (11):bvaa135 Epub 2020 Sept 15
    View PubMed
  33. Genere N, Hurtado MD, Cortes T, Athimulam S, Al Ward R, Callstrom MR, Stan MN, Morris JC, Brito JP. Drivers of the Decision to Biopsy and Follow-Up of Small Suspicious Thyroid Nodules. Endocr Pract. 2020 Aug; 26 (8):857-868
    View PubMed
  34. Genere N, Hurtado MD, Cortes T, Athimulam S, Al Ward R, Callstrom MR, Stan MN, Morris JC, Brito JP. DRIVERS OF THE DECISION TO BIOPSY AND FOLLOW-UP OF SMALL SUSPICIOUS THYROID NODULES. Endocr Pract. 2020 May 14 [Epub ahead of print]
    View PubMed
  35. Stan MN, Castro MR. NONSURGICAL TREATMENT OF THYROID CYSTS - "SEAL THEM UP". Endocr Pract. 2020 May; 26 (5):573-575
    View PubMed
  36. Brito JP, Payne S, Singh Ospina N, Rodriguez-Gutierrez R, Maraka S, Sangaralingham LR, Iniguez-Ariza NM, Montori VM, Stan MN. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study. Thyroid. 2020 Mar; 30 (3):357-364 Epub 2020 Feb 26
    View PubMed
  37. Stan MN, Kahaly GJ, Stan MN, Frommer L, Gergely P, Colin L, Amer A, Schuhmann I, Espie P, Rush JS, Basson C, He Y. A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, for Control of Graves Hyperthyroidism-A Proof-of-Concept Trial. J Clin Endocrinol Metab. 2020 Mar 1; 105 (3)
    View PubMed
  38. Gonzales KM, Stan MN, Morris JC 3rd, Bernet V, Castro MR. The Levothyroxine Absorption Test: A Four-Year Experience (2015-2018) at The Mayo Clinic. Thyroid. 2019 Dec; 29 (12):1734-1742 Epub 2019 Dec 04
    View PubMed
  39. Kahaly GJ, Stan MN, Frommer L, Gergely P, Colin L, Amer A, Schuhmann I, Espie P, Rush JS, Basson C, He YL. A Novel Anti-Cd40 Monoclonal Antibody, Iscalimab, for Control of Graves' Hyperthyroidism - A Proof-Of-Concept Trial. J Clin Endocrinol Metab. 2019 Sep 12 Epub 2019 Sept 12
    View PubMed
  40. Maraka S, Mwangi R, Yao X, Sangaralingham LR, Singh Ospina NM, O'Keeffe DT, Rodriguez-Gutierrez R, Stan MN, Brito JP, Montori VM, McCoy RG. Variation in Treatment Practices for Subclinical Hypothyroidism in Pregnancy: US National Assessment. J Clin Endocrinol Metab. 2019 Sep 1; 104 (9):3893-3901
    View PubMed
  41. Sharma A, Stan MN. Thyrotoxicosis: Diagnosis and Management. Mayo Clin Proc. 2019 Jun; 94 (6):1048-1064 Epub 2019 Mar 25
    View PubMed
  42. Kotwal A, Turcu AF, Sonawane V, Bahn RS, Pittelkow MR, Bridges A, Stan MN. Clinical Experience with Rituximab and Intravenous Immunoglobulin for Pretibial Myxedema: A Case Series. Thyroid. 2019 May; 29 (5):692-699 Epub 2019 Apr 08
    View PubMed
  43. Genere N, Stan MN. Current and Emerging Treatment Strategies for Graves' Orbitopathy. Drugs. 2019 Feb; 79 (2):109-124
    View PubMed
  44. Kotwal A, Stan M. Current and Future Treatments for Graves' Disease and Graves' Ophthalmopathy. Horm Metab Res. 2018 Dec; 50 (12):871-886 Epub 2018 Oct 04
    View PubMed
  45. Kotwal A, Clark J, Lyden M, McKenzie T, Thompson G, Stan MN. Thyroidectomy for Amiodarone-Induced Thyrotoxicosis: Mayo Clinic Experience. J Endocr Soc. 2018 Nov 1; 2 (11):1226-1235 Epub 2018 Sept 06
    View PubMed
  46. Iniguez-Ariza NM, Lee RA, Singh-Ospina NM, Stan MN, Castro MR. Ethanol Ablation for the Treatment of Cystic and Predominantly Cystic Thyroid Nodules. Mayo Clin Proc. 2018 Aug; 93 (8):1009-1017 Epub 2018 July 04
    View PubMed
  47. Hamidi O, Callstrom MR, Lee RA, Dean D, Castro MR, Morris JC, Stan MN. Outcomes of Radiofrequency Ablation Therapy for Large Benign Thyroid Nodules: A Mayo Clinic Case Series. Mayo Clin Proc. 2018 Aug; 93 (8):1018-1025 Epub 2018 Mar 21
    View PubMed
  48. Farhadfar N, Stan MN, Shah P, Sonawane V, Hefazi MT, Murthy HS, Zou F, Sican X, Hashmi SK. Thyroid dysfunction in adult hematopoietic cell transplant survivors: risks and outcomes. Bone Marrow Transplant. 2018 Aug; 53 (8):977-982 Epub 2018 Feb 06
    View PubMed
  49. Kotwal A, Stan M. Thyrotropin Receptor Antibodies-An Overview. Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug; 34 (4S Suppl 1):S20-S27
    View PubMed
  50. Maraka ,, Dean ,, Fatourechi ,, Castro ,, Bahn ,, Thapa ,, Stan ,. Prevention of Overt Hypothyroidism following Radioactive Iodine Therapy for Graves' Disease by Early Initiation of Levothyroxine Therapy 87th Annual Meeting of the American Thyroid Association. 2018.
  51. El-Harasis MA, DeSimone CV, Stan MN, McLeod CJ, Noseworthy PA. Graves' disease-induced complete heart block and asystole. HeartRhythm Case Rep. 2018 Mar; 4 (3):105-108 Epub 2017 Dec 29
    View PubMed
  52. Iniguez-Ariza NM, Stan MN, Bible KC. Effect of thyroid hormone suppression on control of advanced well-differentiated thyroid cancer. Endocrine. 2018 Jan; 59 (1):228-229 Epub 2017 Nov 01
    View PubMed
  53. Sundaresh V, Brito JP, Thapa P, Bahn RS, Stan MN. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study. Thyroid. 2017 Apr; 27 (4):497-505 Epub 2017 Feb 06
    View PubMed
  54. Stan MN, Sonawane V, Sebo TJ, Thapa P, Bahn RS. Riedel's thyroiditis association with IgG4-related disease. Clin Endocrinol (Oxf). 2017 Mar; 86(3):425-430. Epub 2016 Oct 07.
    View PubMed
  55. Stan MN, Salvi M. MANAGEMENT OF ENDOCRINE DISEASE: Rituximab therapy for Graves' orbitopathy - lessons from randomized control trials. Eur J Endocrinol. 2017 Feb; 176: (2)R101-R109.
    View PubMed
  56. Maraka S, Mwangi R, McCoy RG, Yao X, Sangaralingham LR, Singh Ospina NM, O'Keeffe DT, De Ycaza AE, Rodriguez-Gutierrez R, Coddington CC 3rd, Stan MN, Brito JP, Montori VM. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment. BMJ. 2017 Jan 25; 356:i6865
    View PubMed
  57. Espinosa De Ycaza AE, Lowe KM, Dean DS, Castro MR, Fatourechi V, Ryder M, Morris JC, Stan MN. Risk of Malignancy in Thyroid Nodules with Non-Diagnostic Fine-Needle Aspiration: A Retrospective Cohort Study. Thyroid. 2016 Nov; 26 (11):1598-1604 Epub 2016 Oct 05
    View PubMed
  58. Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016 Oct; 26 (10):1343-1421
    View PubMed
  59. Sharma A, Jasim S, Reading CC, Ristow KM, Villasboas Bisneto JC, Habermann TM, Fatourechi V, Stan M. Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma: A Cohort Study. Thyroid. 2016 Aug; 26 (8):1061-7 Epub 2016 July 06
    View PubMed
  60. Maraka S, Singh Ospina NM, O'Keeffe DT, Rodriguez-Gutierrez R, Espinosa De Ycaza AE, Wi CI, Juhn YJ, Coddington CC 3rd, Montori VM, Stan MN. Effects of Levothyroxine Therapy on Pregnancy Outcomes in Women with Subclinical Hypothyroidism. Thyroid. 2016 Jul; 26 (7):980-6 Epub 2016 May 16
    View PubMed
  61. Maraka S, Ospina NM, O'Keeffe DT, Espinosa De Ycaza AE, Gionfriddo MR, Erwin PJ, Coddington CC 3rd, Stan MN, Murad MH, Montori VM. Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis. Thyroid. 2016 Apr; 26 (4):580-90 Epub 2016 Mar 03
    View PubMed
  62. Brito JP, Castaneda-Guarderas A, Gionfriddo MR, Ospina NS, Maraka S, Dean DS, Castro MR, Fatourechi V, Gharib H, Stan MN, Branda ME, Bahn RS, Montori VM. Development and Pilot Testing of an Encounter Tool for Shared Decision Making About the Treatment of Graves' Disease. Thyroid. 2015 Nov; 25 (11):1191-8 Epub 2015 Oct 15
    View PubMed
  63. Shah M, Bancos I, Thompson GB, Richards ML, Kasperbauer JL, Clarke BL, Drake MT, Stan MN. Teriparatide Therapy and Reduced Postoperative Hospitalization for Postsurgical Hypoparathyroidism. JAMA Otolaryngol Head Neck Surg. 2015 Sep; 141: (9)822-7.
    View PubMed
  64. Stan MN, Haglind EG, Drake MT. Early Hypoparathyroidism Reversibility with Treatment of Riedel's Thyroiditis. Thyroid. 2015 Sep; 25: (9)1055-9.
    View PubMed
  65. Brito JP, Castro MR, Dean DS, Fatourechi V, Stan M. Survey of current approaches to non-diagnostic fine-needle aspiration from solid thyroid nodules. Endocrine. 2015 Aug; 49 (3):745-51 Epub 2015 Feb 04
    View PubMed
  66. Stan MN, Garrity JA, Carranza Leon BG, Prabin T, Bradley EA, Bahn RS. Randomized controlled trial of rituximab in patients with Graves' orbitopathy. J Clin Endocrinol Metab. 2015 Feb; 100 (2):432-41 Epub 2014 Oct 24
    View PubMed
  67. PTH in post-surgical hypoparathyroidism 84th Annual Meeting of the American Thyroid Association Program. 2014.
  68. Brito JP, Gionfriddo MR, Al Nofal A, Boehmer KR, Leppin AL, Reading C, Callstrom M, Elraiyah TA, Prokop LJ, Stan MN, Murad MH, Morris JC, Montori VM. The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis. J Clin Endocrinol Metab. 2014 Apr; 99 (4):1253-63 Epub 2013 Nov 25
    View PubMed
  69. Stan MN, Sathananthan M, Warnes CA, Brennan MD, Thapa P, Bahn RS. Amiodarone-induced thyrotoxicosis in adults with congenital heart disease--clinical presentation and response to therapy. Endocr Pract. 2014 Jan; 20 (1):33-40
    View PubMed
  70. Sundaresh V, Brito JP, Wang Z, Prokop LJ, Stan MN, Murad MH, Bahn RS. Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis. J Clin Endocrinol Metab. 2013 Sep; 98 (9):3671-7 Epub 2013 July 03
    View PubMed
  71. Stan MN, Ammash NM, Warnes CA, Brennan MD, Thapa P, Nannenga MR, Bahn RS. Body mass index and the development of amiodarone-induced thyrotoxicosis in adults with congenital heart disease--a cohort study. Int J Cardiol. 2013 Aug 10; 167 (3):821-6 Epub 2012 Mar 02
    View PubMed
  72. Adhikari LJ, Sciallis AP, Reynolds J, Jenkins S, Smith C, Stan MN, Nassar A. Clinicopathologic predictors of thyroid bed recurrence of differentiated thyroid cancer using ultrasound-guided fine-needle aspiration biopsies. Thyroid. 2013 Aug; 23(8):982-8.
    View PubMed
  73. Stan MN, Durski JM, Brito JP, Bhagra S, Thapa P, Bahn RS. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment. Thyroid. 2013 May; 23 (5):620-5
    View PubMed
  74. Bancos I, Grant CS, Nadeem S, Stan MN, Reading CC, Sebo TJ, Algeciras-Schimnich A, Singh RJ, Dean DS. Risks and benefits of parathyroid fine-needle aspiration with parathyroid hormone washout. Endocr Pract. 2012 Jul-Aug; 18 (4):441-9
    View PubMed
  75. Stan MN, Garrity JA, Bahn RS. The evaluation and treatment of graves ophthalmopathy. Med Clin North Am. 2012 Mar; 96 (2):311-28 Epub 2012 Feb 22
    View PubMed
  76. Stan MN, Hess EP, Bahn RS, Warnes CA, Ammash NM, Brennan MD, Thapa P, Montori VM. A risk prediction index for amiodarone-induced thyrotoxicosis in adults with congenital heart disease. J Thyroid Res. 2012; 2012:210529 Epub 2012 Feb 12
    View PubMed
  77. Widmer RJ, Erickson D, Stan MN, McKusick MA, Garovic VD. Multiple causes for secondary hypertension in a young female. Nephology Reviews. 2012; 4(1).
  78. Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN, American Thyroid Association//American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011 Jun; 21 (6):593-646 Epub 2011 Apr 21
    View PubMed
  79. Kumar S, Nadeem S, Stan MN, Coenen M, Bahn RS. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. J Mol Endocrinol. 2011 Jun; 46 (3):155-63 Epub 2011 Apr 12
    View PubMed
  80. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN, American Thyroid Association//American Association of Clinical Endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011 May-Jun; 17 (3):456-520
    View PubMed
  81. Stan MN, Bahn RS. Risk factors for development or deterioration of Graves' ophthalmopathy. Thyroid. 2010 Jul; 20 (7):777-83
    View PubMed
  82. Bahn RS, Burch HS, Cooper DS, Garber JR, Greenlee CM, Klein IL, Laurberg P, McDougall IR, Rivkees SA, Ross D, Sosa JA, Stan MN. The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid. 2009 Jul; 19(7):673-4.
    View PubMed
  83. Espiritu RP, Stan MN. Rhabdomyolysis after withdrawal of thyroid hormone in a patient with papillary thyroid cancer. Endocr Pract. 2008 Nov; 14 (8):1023-6
    View PubMed
  84. Stan MN, Garrity JA, Bradley EA, Woog JJ, Bahn MM, Brennan MD, Bryant SC, Achenbach SJ, Bahn RS. Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy. J Clin Endocrinol Metab. 2006 Dec; 91 (12):4817-24 Epub 2006 Sept 19
    View PubMed
  85. Stan M, Morris JC. Thyrotropin-axis adaptation in aging and chronic disease. Endocrinol Metab Clin North Am. 2005 Dec; 34(4):973-92, x.
    View PubMed